Waldencast plc SEC Filing Summary

Waldencast plc announced on April 28, 2026, that the SEC has concluded its investigation into the company concerning the restatement of financial results and material weaknesses in internal control over financial reporting. The SEC has indicated that it does not intend to recommend an enforcement action against Waldencast. The company fully cooperated with the investigation, which related to historical accounting practices of Obagi Cosmeceuticals. Waldencast incurred substantial costs related to the investigation. The company, founded by Michel Brousset and Hind Sebti, aims to build a global beauty and wellness platform through brand development and acquisition, emphasizing a brand-led business model. The filing also provides brief information about its brands, Obagi Medical and Milk Makeup, and contact details for investors and media.